Science and Research
Derby: Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
This is a 24-month study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy secondary to age-related macular degeneration.
Overview
This is a Phase III, multicentre, randomised, double-masked, sham-injection controlled study to assess the efficacy and safety of multiple IVT injections of APL-2 in patients with geographic atrophy secondary to age-related macular degeneration.
- Principal Investigator
Associate Professor Sanj Wickremasinghe
This is a Phase III, multicentre, randomised, double-masked, sham-injection controlled study to assess the efficacy and safety of multiple IVT injections of APL-2 in patients with geographic atrophy secondary to age-related macular degeneration.
- Principal Investigator
Learn more
View this study at ClinicalTrials.gov
This international database listing provides more detailed information about this study.